A cost of illness model to estimate the annual societal costs of X-linked retinitis pigmentosa (XLRP) in the United Kingdom (UK)
Theme: Patient Experience Data
The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-of-Illness Perspective
The socioeconomic impact of inherited retinal dystrophies (IRDs) in Canada
The socioeconomic impact of inherited retinal dystrophies (IRDs) in the United Kingdom
The socioeconomic impact of inherited retinal dystrophies (IRDs) in the Republic of Ireland
The Landscape of Genomic Services for Inherited Retinal Degenerations (IRDs) Across Europe
Genetic Testing Experiences of People Living with Inherited Retinal Degenerations: Results of a Global Survey
Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US
Valuing patients’ high unmet need to drive innovative therapies for inherited retinal degenerations: insights from the RIWC 2024 workshop on value
Prioritising the Burden of Geographic Atrophy and Treatment Expectations: A Modified Nominal Group Technique Study with International Patient-Led Organisations
IRDCOUNTS: Cost-of-Illness Studies
-
close